Ambulero, Inc.
PrivateLast Round
VC Round
Jan 25, 2021
Company Overview
Ambulero, Inc. is a biotechnology company that develops cell and gene therapies for the treatment of vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambulero, Inc. Comparables
Compare Ambulero, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ixaka Ltd | 84% | |
| BioGenCell | 84% | |
| Libella Gene Therapeutics | 80% |
Ambulero, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 25, 2021 |
Ambulero, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orphinic Scientific SA | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors increased 187% MoM.
- Jan 25, 2021
$5.5M round led by Orphinic Scientific SA
Ambulero, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ambulero, Inc.'s valuation, stock price, and market status.
Is Ambulero, Inc. a public or private company?
Ambulero, Inc. is a private company.
What is the current stock price of Ambulero, Inc.?
Ambulero, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Ambulero, Inc. worth (valuation)?
Valuation information for Ambulero, Inc. is not publicly available.
Can I buy Ambulero, Inc. stock?
Ambulero, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ambulero, Inc.'s last funding round?
Ambulero, Inc.'s most recent funding round was VC Round on January 25, 2021.
Who are the main investors in Ambulero, Inc.?
Key investors in Ambulero, Inc. include Orphinic Scientific SA.
Will Ambulero, Inc. IPO soon?
No public IPO plans have been announced for Ambulero, Inc..
How can I track Ambulero, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ambulero, Inc.'s secondary market activity and sign up for updates.